Gsk (GSK) Revenue (2009 - 2025)

Gsk's Revenue history runs 16 years deep, the most recent figure standing at $43.1 billion for FY2025.

• In Q1 2026, Revenue rose 8.65% year-over-year to $10.3 billion; the TTM figure through Mar 2026 stood at $43.9 billion (down 11.06% YoY), while the FY2025 annual figure was $43.1 billion, up 7.39% from the prior year.
• Revenue was $43.1 billion for FY2025 at Gsk, up from $40.1 billion in the prior year.
• In the past five years, Revenue ranged from a high of $43.1 billion in FY2025 to a low of $34.0 billion in FY2021.
• Historically, Revenue has averaged $38.2 billion across 5 years, with a median of $37.7 billion in 2023.
• The sharpest annual moves came in 2021 and 2023: Revenue gained 8.65% in 2021, then rose 3.94% in 2023.
• A 5-year view of Revenue shows it stood at $34.0 billion in 2021, then gained by 6.81% to $36.3 billion in 2022, then grew by 3.94% to $37.7 billion in 2023, then climbed by 6.32% to $40.1 billion in 2024, then rose by 7.39% to $43.1 billion in 2025.
• The last three Revenue figures came in at $43.1 billion (FY2025), $40.1 billion (FY2024), and $37.7 billion (FY2023), per Business Quant data.